Whitehawk Therapeutics (WHWK) Preferred Dividend Payments (2016 - 2017)
Whitehawk Therapeutics (WHWK) reported Preferred Dividend Payments of $943297.0 for Q1 2017, down 7.1% year-over-year from $1.0 million in Q1 2016, and down 10.56% on a QoQ basis from $1.1 million in Q4 2016.
Whitehawk Therapeutics (WHWK) has 2 years of Preferred Dividend Payments data on file, last reported at $943297.0 in Q1 2017.
- Quarterly Preferred Dividend Payments fell 7.1% year-over-year to $943297.0 in Q1 2017, while the trailing twelve-month figure through Dec 2017 was $943297.0 (down 77.29% YoY) and the FY2021 annual result came in at $647000.0, changed N/A from the prior year.
- Preferred Dividend Payments declined to $943297.0 in Q1 2017 per WHWK's latest filing, from $1.1 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $1.1 million in Q3 2016 and bottomed at $943297.0 in Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 943,297.00 |
| Dec 31, 2016 | 1.05 Mn |
| Sep 30, 2016 | 1.05 Mn |
| Jun 30, 2016 | 1.03 Mn |
| Mar 31, 2016 | 1.02 Mn |